Center for Drug Design - University of Minnesota
Research ServicesMinnesota, United States11-50 Employees
The Center for Drug Design (CDD) at the University of Minnesota operates as a research unit within the College of Pharmacy, focused on medicinal chemistry and the design and development of new therapies. Its work includes patents across cancer, antiviral, and antimicrobial areas and features contributions to drug development such as carbovir, an anti-HIV/AIDS agent marketed as Ziagen by GlaxoSmithKline. The center was established on January 8, 2002 after approval from university leadership, and it is positioned as a center of excellence in drug design and research. Based in Minneapolis, Minnesota, the CDD comprises a small team that blends academic tradition with opportunities for innovative, independent inquiry. It seeks to advance its members' work while delivering value to the broader academic and research community through rigorous drug-design activities. Overall, the center sits within the university's research services ecosystem, prioritizing scholarly impact over commercial expansion.